Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 12, pp. 1538-1547
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
Eshan U. Patel, Evan M. Bloch, William Clarke, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 2
Open Access | Times Cited: 191
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 176
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
Andrea Padoan, Francesco Bonfante, Matteo Pagliari, et al.
EBioMedicine (2020) Vol. 62, pp. 103101-103101
Open Access | Times Cited: 143
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Antonin Bal, Bruno Pozzetto, Mary‐Anne Trabaud, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 5, pp. 742-752
Open Access | Times Cited: 82
A novel highly quantitative and reproducible assay for the detection of anti-SARS-CoV-2 IgG and IgM antibodies
Kenta Noda, Kouki Matsuda, Shigehiro Yagishita, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 66
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Teresa R. Wagner, E. Ostertag, Philipp D. Kaiser, et al.
EMBO Reports (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 58
Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E. Clark, et al.
Vaccines (2021) Vol. 9, Iss. 7, pp. 708-708
Open Access | Times Cited: 57
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Maggie Li, E. Beck, Oliver Laeyendecker, et al.
Blood Advances (2022) Vol. 6, Iss. 12, pp. 3678-3683
Open Access | Times Cited: 54
Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
Natalie Hofmann, Marica Grossegesse, Markus Neumann, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
Kuan‐Ting Liu, Yi-Ju Han, Guan-Hong Wu, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1560-1560
Open Access | Times Cited: 39
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
SARS-CoV-2 seroprevalence in Spain – Authors' reply
Marina Pollán, Beatriz Pérez‐Gómez, Roberto Pastor‐Barriuso, et al.
The Lancet (2020) Vol. 396, Iss. 10261, pp. 1484-1485
Open Access | Times Cited: 63
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
Mary‐Anne Trabaud, Vinca Icard, Marie-Paule Milon, et al.
Journal of Clinical Virology (2020) Vol. 132, pp. 104613-104613
Open Access | Times Cited: 58
Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay–Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays
Vijayalakshmi Nandakumar, Tracie Profaizer, Bucky K. Lozier, et al.
Archives of Pathology & Laboratory Medicine (2021) Vol. 145, Iss. 10, pp. 1212-1220
Open Access | Times Cited: 43
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Isabel Montesinos, Hafid Dahma, Fleur Wolff, et al.
Journal of Clinical Virology (2021) Vol. 144, pp. 104988-104988
Open Access | Times Cited: 43
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays
Sojeong Yun, Ji Hyeong Ryu, Joo Hee Jang, et al.
Annals of Laboratory Medicine (2021) Vol. 41, Iss. 6, pp. 577-587
Open Access | Times Cited: 40
Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
Anastasia Parthymou, Evagelia E Habeos, George I. Habeos, et al.
BMJ Open (2022) Vol. 12, Iss. 5, pp. e057084-e057084
Open Access | Times Cited: 36
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 35
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis
Frauke Muecksch, Helen Wise, Kate Templeton, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 7, pp. e493-e502
Open Access | Times Cited: 32
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Anna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3989-3989
Open Access | Times Cited: 48
Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities
Erika P. Orner, Mary A. Rodgers, Karl Hock, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 4, pp. 115300-115300
Open Access | Times Cited: 39
Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
Yoonjoo Kim, Ji Hyun Lee, Geon Young Ko, et al.
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1496-1496
Open Access | Times Cited: 38
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Maureen Betton, Marine Livrozet, Delphine Planas, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 6, pp. e1337-e1344
Open Access | Times Cited: 37
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects
Anat Achiron, Michael Gurevich, Rina Falb, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 9, pp. 1349.e1-1349.e6
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top